Publication Cover
Stress
The International Journal on the Biology of Stress
Volume 11, 2008 - Issue 1
1,844
Views
67
CrossRef citations to date
0
Altmetric
Original

HPA axis and sleep: Identifying subtypes of major depression

Review

&
Pages 15-27 | Received 22 Oct 2006, Accepted 31 Mar 2007, Published online: 07 Jul 2009

References

  • Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K. Toward validation of atypical depression in the community: Results of the Zurich cohort study. J Affect Disord 2002; 72: 125–138
  • Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 1999; 4: 182–188
  • Antonijevic IA, Murck H, Frieboes RM, Barthelmes J, Steiger A. Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls—part I: The sleep EEG. Sleep Res Online 2000a; 3: 5–13
  • Antonijevic IA, Murck H, Frieboes RM, Steiger A. Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls—part II: Hormone secretion. Sleep Res Online 2000b; 3: 15–21
  • Antonijevic IA, Murck H, Frieboes RM, Uhr M, Steiger A. On the role of menopause for sleep-endocrine alterations associated with major depression. Psychoneuroendocrinology 2003; 28: 401–418
  • Armitage R, Hoffmann R, Trivedi M, Rush AJ. Slow-wave activity in NREM sleep: Sex and age effects in depressed outpatients and healthy controls. Psychiatry Res 2000; 95: 201–213
  • Armitage R, Emslie GJ, Hoffmann RF, Rintelmann J, Rush AJ. Delta sleep EEG in depressed adolescent females and healthy controls. J Affect Disord 2001; 63: 139–148
  • Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Novacenko H, Ostrow LC. Cortisol secretion in relation to age in major depression. Psychosom Med 1981a; 43: 235–242
  • Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Ostrow L, Halpern FS. Cortisol secretion and dexamethasone response in depression. Am J Psychiatry 1981b; 138: 1218–1221
  • Brodaty H, Cullen B, Thompson C, Mitchell P, Parker G, Wilhelm K, Austin MP, Malhi G. Age and gender in the phenomenology of depression. Am J Geriatr Psychiatry 2005; 13: 589–596
  • Buysse DJ, Frank E, Lowe KK, Cherry CR, Kupfer DJ. Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol Psychiatry 1997; 41: 406–418
  • Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 1976a; 33: 1039–1044
  • Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 1976b; 33: 1051–1058
  • Carroll BJ, Cassidy F, Naftolowitz D, Tatham NE, Wilson WH, Iranmesh A, Liu PY, Veldhuis JD. Pathophysiology of hypercortisolism in depression. Acta Psychiatr Scand 2007; 115: 90–103
  • Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386–389
  • Coryell W. The facets of melancholia. Acta Psychiatr Scand Suppl 2007; 31–36
  • Coryell W, Schlesser M. Combined biological tests for suicide prediction. Psychiatry Res 2007; 150(2)
  • Coryell W, Young E, Carroll B. Hyperactivity of the hypothalamic–pituitary–adrenal axis and mortality in major depressive disorder. Psychiatry Res 2006; 142: 99–104
  • Dallman MF, Pecoraro NC, la Fleur SE. Chronic stress and comfort foods: Self-medication and abdominal obesity. Brain Behav Immun 2005; 19: 275–280
  • de Kloet ER, Joels M, Holsboer F. Stress and the brain: From adaptation to disease. Nat Rev Neurosci 2005; 6: 463–475
  • Dijk DJ. EEG slow waves and sleep spindles: Windows on the sleeping brain. Behav Brain Res 1995; 69: 109–116
  • Fava M. Pharmacological approaches to the treatment of residual symptoms. J Psychopharmacol 2006; 20: 29–34
  • Foster FG, Kupfer DJ, Coble P, McPartland RJ. Rapid eye movement sleep density. An objective indicator in severe medical-depressive syndromes. Arch Gen Psychiatry 1976; 33: 1119–1123
  • Fountoulakis KN, Iacovides A, Kaprinis S, Kaprinis G. Life events and clinical subtypes of major depression: A cross-sectional study. Psychiatry Res 2006; 143: 235–244
  • Geracioti TD, Jr., Loosen PT, Orth DN. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol Psychiatry 1997; 42: 165–174
  • Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs. low CRH/NE states. Mol Psychiatry 2002; 7: 254–275
  • Gold PW, Licinio J, Wong ML, Chrousos GP. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann NY Acad Sci 1995; 771: 716–729
  • Gold PW, Wong ML, Goldstein DS, Gold HK, Ronsaville DS, Esler M, Alesci S, Masood A, et al. Cardiac implications of increased arterial entry and reversible 24 h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci USA 2005; 102: 8303–8308
  • Greden JF, Flegel P, Haskett R, Dilsaver S, Carroll BJ, Grunhaus L, Genero N. Age effects in serial hypothalamic–pituitary–adrenal monitoring. Psychoneuroendocrinology 1986; 11: 195–204
  • Hatzinger M, Hemmeter UM, Baumann K, Brand S, Holsboer-Trachsler E. The combined DEX–CRH test in treatment course and long-term outcome of major depression. J Psychiatr Res 2002; 36: 287–297
  • Hatzinger M, Hemmeter UM, Brand S, Ising M, Holsboer-Trachsler E. Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: Association with DEX/CRH-test response. J Psychiatr Res 2004; 38: 453–465
  • Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB. Pituitary–adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000; 284: 592–597
  • Heim C, Plotsky PM, Nemeroff CB. Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 2004; 29: 641–648
  • Hermus AR, Pieters GF, Pesman GJ, Hofman J, Smals AG, Benraad TJ, Kloppenborg PW. Escape from dexamethasone-induced ACTH and cortisol suppression by corticotrophin-releasing hormone: Modulatory effect of basal dexamethasone levels. Clin Endocrinol (Oxf) 1987; 26: 67–74
  • Heuser I, Yassouridis A, Holsboer F. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J Psychiatr Res 1994; 28: 341–356
  • Ising M, Kunzel HE, Binder EB, Nickel T, Modell S, Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1085–1093
  • Jindal RD, Friedman ES, Berman SR, Fasiczka AL, Howland RH, Thase ME. Effects of sertraline on sleep architecture in patients with depression. J Clin Psychopharmacol 2003; 23: 540–548
  • Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, Arolt V, Cassens U, et al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 2005; 87: 305–311
  • Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH, Schatzberg AF. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry 2006; 60(3)
  • Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: A replication. Arch Gen Psychiatry 2005; 62: 529–535
  • Khan AA, Gardner CO, Prescott CA, Kendler KS. Gender differences in the symptoms of major depression in opposite-sex dizygotic twin pairs. Am J Psychiatry 2002; 159: 1427–1429
  • Khan AY, Carrithers J, Preskorn SH, Lear R, Wisniewski SR, John RA, Stegman D, Kelley C, et al. Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry 2006; 18: 91–98
  • Kirschbaum C, Pirke KM, Hellhammer DH. The ”Trier Social Stress Test”—a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993; 28: 76–81
  • Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R, Siever LJ. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res 2004; 38: 503–511
  • Krieg JC, Berger M. REM sleep and cortisol response to the cholinergic challenge with RS 86 in normals and depressives. Acta Psychiatr Scand 1987; 76: 600–602
  • Kunzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, et al. Pharmacological and nonpharmacological factors influencing hypothalamic–pituitary–adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex–CRH test. Neuropsychopharmacology 2003; 28: 2169–2178
  • Kupfer DJ. Sleep and depressive syndromes. N Engl J Med 1971; 285: 1490
  • Kupfer DJ. REM latency: A psychobiologic marker for primary depressive disease. Biol Psychiatry 1976; 11: 159–174
  • Kupfer DJ. Sleep research in depressive illness: Clinical implications—a tasting menu. Biol Psychiatry 1995; 38: 391–403
  • Kupfer DJ. Dimensional models for research and diagnosis: A current dilemma. J Abnorm Psychol 2005; 114: 557–559
  • Kupfer DJ, Targ E, Stack J. Electroencephalographic sleep in unipolar depressive subtypes: Support for a biological and familial classification. J Nerv Ment Dis 1982; 170: 494–498
  • Kupfer DJ, Reynolds CF, III, Grochocinski VJ, Ulrich RF, McEachran A. Aspects of short REM latency in affective states: A revisit. Psychiatry Res 1986; 17: 49–59
  • Leonard BE. The HPA and immune axes in stress: The involvement of the serotonergic system. Eur Psychiatry 2005; 20(Suppl 3)S302–S306
  • Levitan RD, Vaccarino FJ, Brown GM, Kennedy SH. Low-dose dexamethasone challenge in women with atypical major depression: Pilot study. J Psychiatry Neurosci 2002; 27: 47–51
  • Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, Copinschi G, Van Cauter E. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: Effect of antidepressant treatment. J Clin Endocrinol Metab 1987; 65: 141–152
  • Maes M. Effects of age and gender on the classification and phenomenology of unipolar depression. Acta Neuropsychiatrica 2002; 14: 29–35
  • Maes M, Meltzer H, Cosyns P, Calabrese J, D'Hondt P, Blockx P. Adrenocorticotropic hormone, beta-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 1273–1292
  • Markus R, Panhuysen G, Tuiten A, Koppeschaar H. Effects of food on cortisol and mood in vulnerable subjects under controllable and uncontrollable stress. Physiol Behav 2000; 70: 333–342
  • McGrath PJ, Stewart JW, Harrison WM, Ocepek-Welikson K, Rabkin JG, Nunes EN, Wager SG, Tricamo E, et al. Predictive value of symptoms of atypical depression for differential drug treatment outcome. J Clin Psychopharmacol 1992; 12: 197–202
  • Meaney MJ, Szyf M. Environmental programming of stress responses through DNA methylation: Life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 2005; 7: 103–123
  • Murck H, Frieboes RM, Antonijevic IA, Steiger A. Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men. Psychopharmacology (Berl) 2001; 155: 187–192
  • Nelson JC, Davis JM. DST studies in psychotic depression: A meta-analysis. Am J Psychiatry 1997; 154: 1497–1503
  • Nierenberg AA, Pava JA, Clancy K, Rosenbaum JF, Fava M. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?. Biol Psychiatry 1996; 40: 691–696
  • Overall JE, Rhoades HM. Use of the Hamilton rating scale for classification of depressive disorders. Compr Psychiatry 1982; 23: 370–376
  • Pace-Schott EF, Hobson JA. The neurobiology of sleep: Genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 2002; 3: 591–605
  • Parker G. Classifying depression: Should paradigms lost be regained?. Am J Psychiatry 2000; 157: 1195–1203
  • Parker G. Evaluating treatments for the mood disorders: Time for the evidence to get real. Aust NZ J Psychiatry 2004; 38: 408–414
  • Parker G. Melancholia. Am J Psychiatry 2005; 162: 1066
  • Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, Hadzi-Pavlovic D. Atypical depression: A reappraisal. Am J Psychiatry 2002; 159: 1470–1479
  • Parker G, Snowdon J, Parker K. Modelling late-life depression. Int J Geriatr Psychiatry 2003; 18: 1102–1109
  • Parker G, Parker K, Mitchell P, Wilhelm K. Atypical depression: Australian and US studies in accord. Curr Opin Psychiatry 2005; 18: 1–5
  • Poland RE, McCracken JT, Lutchmansingh P, Lesser IM, Tondo L, Edwards C, Boone KB, Lin KM. Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects. Biol Psychiatry 1997; 41: 929–938
  • Posternak MA, Zimmerman M. Symptoms of atypical depression. Psychiatry Res 2001; 104: 175–181
  • Posternak MA, Zimmerman M. Partial validation of the atypical features subtype of major depressive disorder. Arch Gen Psychiatry 2002; 59: 70–76
  • Pruessner JC, Champagne F, Meaney MJ, Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: A positron emission tomography study using [11C]raclopride. J Neurosci 2004; 24: 2825–2831
  • Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, et al. Phenelzine versus imipramine in the treatment of probable atypical depression: Defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 1988; 145: 306–311
  • Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wager SG, Nunes E, Rabkin JG, Tricamo E, et al. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression. Arch Gen Psychiatry 1989; 46: 787–793
  • Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K, Nunes E, Harrison W, et al. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Br J Psychiatry Suppl 1993; 30–34
  • Reynolds CF, Kupfer DJ, Thase ME, Frank E, Jarrett DB, Coble PA, Hoch CC, Buysse DJ, et al. Sleep, gender, and depression: An analysis of gender effects on the electroencephalographic sleep of 302 depressed outpatients. Biol Psychiatry 1990; 28: 673–684
  • Rubin RT, Poland RE, Lesser IM, Martin DJ, Blodgett AL, Winston RA. Neuroendocrine aspects of primary endogenous depression III. Cortisol secretion in relation to diagnosis and symptom patterns. Psychol Med 1987a; 17: 609–619
  • Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL. Neuroendocrine aspects of primary endogenous depression I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 1987b; 44: 328–336
  • Rush AJ, Weissenburger JE. Melancholic symptom features and DSM-IV. Am J Psychiatry 1994; 151: 489–498
  • Rydmark I, Wahlberg K, Ghatan PH, Modell S, Nygren A, Ingvar M, Asberg M, Heilig M. Neuroendocrine cognitive and structural imaging characteristics of women on longterm sickleave with job stress-induced depression. Biol Psychiatry 2006
  • Schatzberg AF, Rothschild AJ, Bond TC, Cole JO. The DST in psychotic depression: Diagnostic and pathophysiologic implications. Psychopharmacol Bull 1984; 20: 362–364
  • Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res 1985; 19: 57–64
  • Schreier A, Hofler M, Wittchen HU, Lieb R. Clinical characteristics of major depressive disorder run in families–a community study of 933 mothers and their children. J Psychiatr Res 2006; 40: 283–292
  • Stefos G, Staner L, Kerkhofs M, Hubain P, Mendlewicz J, Linkowski P. Shortened REM latency as a psychobiological marker for psychotic depression? An age-, gender-, and polarity-controlled study. Biol Psychiatry 1998; 44: 1314–1320
  • Steiger A. Sleep and the hypothalamo–pituitary–adrenocortical system. Sleep Med Rev 2002; 6: 125–138
  • Stewart JW, Garfinkel R, Nunes EV, Donovan S, Klein DF. Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol 1998; 18: 429–434
  • Stewart JW, Bruder GE, McGrath PJ, Quitkin FM. Do age of onset and course of illness define biologically distinct groups within atypical depression?. J Abnorm Psychol 2003; 112: 253–262
  • Stewart JW, Quitkin FM, McGrath PJ, Klein DF. Defining the boundaries of atypical depression: Evidence from the HPA axis supports course of illness distinctions. J Affect Disord 2005; 86: 161–167
  • Thase ME, Kupfer DJ, Ulrich RF. Electroencephalographic sleep in psychotic depression. A valid subtype?. Arch Gen Psychiatry 1986; 43: 886–893
  • Thase ME, Kupfer DJ, Buysse DJ, Frank E, Simons AD, McEachran AB, Rashid KF, Grochocinski VJ. Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I Comparison during acute depressive states. Biol Psychiatry 1995a; 38: 506–515
  • Thase ME, Trivedi MH, Rush AJ. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology 1995b; 12: 185–219
  • Thase ME, Buysse DJ, Frank E, Cherry CR, Cornes CL, Mallinger AG, Kupfer DJ. Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles. Am J Psychiatry 1997; 154: 502–509
  • Vgontzas AN, Bixler EO, Chrousos GP. Obesity-related sleepiness and fatigue: The role of the stress system and cytokines. Ann NY Acad Sci 2006; 1083: 329–344
  • Wager S, Robinson D, Goetz R, Nunes E, Gully R, Quitkin F. Cholinergic REM sleep induction in atypical depression. Biol Psychiatry 1990; 27: 441–446
  • Watson S, Gallagher P, Ferrier IN, Young AH. Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders. J Psychiatr Res 2006; 40: 353–359
  • Weaver IC, Meaney MJ, Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 2006; 103: 3480–3485
  • Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002; 5: 375–388
  • Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 2000; 97: 325–330

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.